Published in BMC Pregnancy Childbirth on August 21, 2013
Good clinical outcomes from a 7-year holistic programme of fistula repair in Guinea. Trop Med Int Health (2015) 0.81
Use of a postoperative pad test to identify continence status in women after obstetric vesicovaginal fistula repair: a prospective cohort study. BJOG (2017) 0.75
Beyond repair - family and community reintegration after obstetric fistula surgery: study protocol. Reprod Health (2015) 0.75
Factors associated with the failure of obstetric fistula repair in Guinea: implications for practice. Reprod Health (2016) 0.75
A descriptive longitudinal study protocol: recurrence and pregnancy post-repair of obstetric fistula in Guinea. BMC Pregnancy Childbirth (2016) 0.75
Identifying Patients With Vesicovaginal Fistula at High Risk of Urinary Incontinence After Surgery. Obstet Gynecol (2016) 0.75
Obstetric vesicovaginal fistula as an international public-health problem. Lancet (2006) 3.58
World Health Organization partograph in management of labour. World Health Organization Maternal Health and Safe Motherhood Programme. Lancet (1994) 3.47
Humanitarian ventures or 'fistula tourism?': the ethical perils of pelvic surgery in the developing world. Int Urogynecol J Pelvic Floor Dysfunct (2006) 2.14
Obstructed labor injury complex: obstetric fistula formation and the multifaceted morbidity of maternal birth trauma in the developing world. Obstet Gynecol Surv (1996) 2.01
Obstetric fistula: guiding principles for clinical management and programme development, a new WHO guideline. Int J Gynaecol Obstet (2007) 1.74
Obstetric fistulae: a study of women managed at the Monze Mission Hospital, Zambia. BJOG (2007) 1.70
Spontaneous closure of vesicovaginal fistulas after bladder drainage alone: review of the evidence. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.65
Predicting the risk of failure of closure of obstetric fistula and residual urinary incontinence using a classification system. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.54
Ethical aspects of urinary diversion for women with irreparable obstetric fistulas in developing countries. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.46
Risk factors that predict failure after vaginal repair of obstetric vesicovaginal fistulae. Am J Obstet Gynecol (2009) 1.46
Vesico-vaginal fistulas in developing countries. Int J Gynaecol Obstet (2003) 1.44
Women with obstetric fistula in Ethiopia: a 6-month follow up after surgical treatment. BJOG (2008) 1.38
Eliminating obstetric fistula: progress in partnerships. Int J Gynaecol Obstet (2006) 1.29
The immediate management of fresh obstetric fistulas. Am J Obstet Gynecol (2004) 1.24
Surgical classification of obstetric fistulas. Int J Gynaecol Obstet (1995) 1.22
Maternal morbidity: neglected dimension of safe motherhood in the developing world. Glob Public Health (2012) 1.11
Predictors and outcome of surgical repair of obstetric fistula at a regional referral hospital, Mbarara, western Uganda. BMC Urol (2011) 1.10
The lived experience of Malawian women with obstetric fistula. Cult Health Sex (2009) 1.02
Preventing obstetric fistulas in low-resource countries: insights from a Haddon matrix. Obstet Gynecol Surv (2012) 0.96
Obstetric fistula: the international response. Lancet (2004) 0.94
The Addis Ababa fistula hospital: an holistic approach to the management of patients with vesicovaginal fistulae. Surgeon (2007) 0.92
Obstetric fistula is a "neglected tropical disease". PLoS Negl Trop Dis (2012) 0.90
Psychosocial impact of obstetric fistula in women presenting for surgical care in Tanzania. Int Urogynecol J (2012) 0.87
Urinary symptoms and urodynamics following obstetric genitourinary fistula repair. Int Urogynecol J (2012) 0.86
Immediate indwelling bladder catheterization at postpartum urine leakage--personal experience of 1200 patients. Trop Doct (1997) 0.85
A community program for women's health and development: implications for the long-term care of women with fistulas. Int J Gynaecol Obstet (2007) 0.84
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS (2006) 5.13
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet (2011) 5.00
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat Med (2013) 4.86
Operational research in low-income countries: what, why, and how? Lancet Infect Dis (2009) 4.56
The HIV-associated tuberculosis epidemic--when will we act? Lancet (2010) 3.82
Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma. J Clin Oncol (2009) 3.80
Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi. J Acquir Immune Defic Syndr (2007) 3.71
Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med (2010) 3.53
Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One (2006) 3.26
Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system? Trans R Soc Trop Med Hyg (2010) 2.96
Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health (2010) 2.92
Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea. Lancet (2008) 2.89
Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis (2012) 2.62
Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Trans R Soc Trop Med Hyg (2004) 2.51
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell (2010) 2.26
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 2.20
Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health (2010) 2.19
In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS (2006) 2.11
Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia. BMC Pediatr (2009) 2.10
Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Trop Med Int Health (2007) 2.09
Operative procedures in the elderly in low-resource settings: a review of Médecins Sans Frontières facilities. World J Surg (2015) 2.01
Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care. BMC Pediatr (2008) 1.96
Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries. J Acquir Immune Defic Syndr (2009) 1.91
Operative mortality in resource-limited settings: the experience of Medecins Sans Frontieres in 13 countries. Arch Surg (2010) 1.89
Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS One (2010) 1.89
A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health (2009) 1.87
High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. Trans R Soc Trop Med Hyg (2007) 1.82
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest (2013) 1.80
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India. PLoS One (2011) 1.70
Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies. J Infect Dis (2007) 1.70
Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India. PLoS One (2012) 1.69
Vector control in a malaria epidemic occurring within a complex emergency situation in Burundi: a case study. Malar J (2007) 1.66
Keeping health facilities safe: one way of strengthening the interaction between disease-specific programmes and health systems. Trop Med Int Health (2010) 1.66
Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Trop Med Int Health (2005) 1.63
MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One (2011) 1.61
Cohort monitoring of persons with hypertension: an illustrated example from a primary healthcare clinic for Palestine refugees in Jordan. Trop Med Int Health (2012) 1.60
Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health (2012) 1.58
Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi. Trop Med Int Health (2009) 1.51
Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa. PLoS Med (2008) 1.49
HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand. Trans R Soc Trop Med Hyg (2008) 1.48
Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis (2010) 1.47
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda. Trans R Soc Trop Med Hyg (2009) 1.47
Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Med J (2010) 1.46
Research to policy and practice change: is capacity building in operational research delivering the goods? Trop Med Int Health (2014) 1.38
Outcomes of TB treatment by HIV status in national recording systems in Brazil, 2003-2008. PLoS One (2012) 1.37
Ethics of conducting research in conflict settings. Confl Health (2009) 1.34
Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clin Infect Dis (2007) 1.34
Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health (2015) 1.33
Virus combinations and chemotherapy for the treatment of human cancers. Curr Opin Mol Ther (2008) 1.32
Directed evolution generates a novel oncolytic virus for the treatment of colon cancer. PLoS One (2008) 1.30
Mortality profiles in a country facing epidemiological transition: an analysis of registered data. BMC Public Health (2009) 1.29
Low referral completion of rapid diagnostic test-negative patients in community-based treatment of malaria in Sierra Leone. Malar J (2011) 1.29
Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health (2012) 1.27
Evaluation of a systematic substitution of zidovudine for stavudine-based HAART in a program setting in rural Cambodia. J Acquir Immune Defic Syndr (2008) 1.25
Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres. PLoS One (2012) 1.25
The vital signs of chronic disease management. Trans R Soc Trop Med Hyg (2009) 1.24
Cohort monitoring of persons with diabetes mellitus in a primary healthcare clinic for Palestine refugees in Jordan. Trop Med Int Health (2012) 1.23
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol (2013) 1.22
HIV and tuberculosis--science and implementation to turn the tide and reduce deaths. J Int AIDS Soc (2012) 1.21
Implementation and outcomes of an active defaulter tracing system for HIV, prevention of mother to child transmission of HIV (PMTCT), and TB patients in Kibera, Nairobi, Kenya. Trans R Soc Trop Med Hyg (2011) 1.19
High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. J Int AIDS Soc (2010) 1.18
'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health (2013) 1.17
Abolishing user fees for children and pregnant women trebled uptake of malaria-related interventions in Kangaba, Mali. Health Policy Plan (2011) 1.14
National and sub-national under-five mortality profiles in Peru: a basis for informed policy decisions. BMC Public Health (2006) 1.10
Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. J Histochem Cytochem (2007) 1.10
No cash, no care: how user fees endanger health--lessons learnt regarding financial barriers to healthcare services in Burundi, Sierra Leone, Democratic Republic of Congo, Chad, Haiti and Mali. Int Health (2011) 1.08
Rethinking surgical care in conflict. Lancet (2010) 1.08
Improving effective surgical delivery in humanitarian disasters: lessons from Haiti. PLoS Med (2011) 1.08
Lost to follow up from tuberculosis treatment in an urban informal settlement (Kibera), Nairobi, Kenya: what are the rates and determinants? Trans R Soc Trop Med Hyg (2011) 1.07
Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa. Trans R Soc Trop Med Hyg (2010) 1.07
SEMAC-VAT and MSVAT-SPACE sequence strategies for metal artifact reduction in 1.5T magnetic resonance imaging. Invest Radiol (2012) 1.06
Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval. Cytokine Growth Factor Rev (2010) 1.06
Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study. BMC Med (2009) 1.06
Responding to major burn disasters in resource-limited settings: lessons learned from an oil tanker explosion in Nakuru, Kenya. J Trauma (2011) 1.06
Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings. Lancet (2006) 1.05
Cesarean section surgical site infections in sub-Saharan Africa: a multi-country study from Medecins Sans Frontieres. World J Surg (2015) 1.05
Pooled HIV-1 viral load testing using dried blood spots to reduce the cost of monitoring antiretroviral treatment in a resource-limited setting. J Acquir Immune Defic Syndr (2013) 1.02
The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India. BMC Public Health (2011) 1.02
A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi. Clin Infect Dis (2012) 1.02
Reliability and accuracy of the South African Triage Scale when used by nurses in the emergency department of Timergara Hospital, Pakistan. S Afr Med J (2014) 1.01
Implementation of a comprehensive program including psycho-social and treatment literacy activities to improve adherence to HIV care and treatment for a pediatric population in Kenya. BMC Pediatr (2008) 1.01
Providing emergency care and assessing a patient triage system in a referral hospital in Somaliland: a cross-sectional study. BMC Health Serv Res (2014) 1.01
Surgical care for the direct and indirect victims of violence in the eastern Democratic Republic of Congo. Confl Health (2010) 1.00
Short and long term retention in antiretroviral care in health facilities in rural Malawi and Zimbabwe. BMC Health Serv Res (2012) 0.98
The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective. Bull World Health Organ (2002) 0.98
Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 0.97
Providing HIV care in the aftermath of Kenya's post-election violence Medecins Sans Frontieres' lessons learned January - March 2008. Confl Health (2008) 0.97
Quality of care in humanitarian surgery. World J Surg (2011) 0.96